TAK 13.1 (+0.69%)
US8740602052Drug ManufacturersDrug Manufacturers - Specialty & Generic

Takeda Pharmaceutical (TAK) Stock Highlights

13.1 | +0.69%
2024-12-21 00:21:48
Takeda Pharmaceutical is Japans largest pharmaceutical company, with revenue of JPY 3.6 trillion in fiscal 2021. The companys five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.

Statistics

Range Today
13.02 13.19
Volume Today 1.85M
Range 1 Year
12.58 15.08
Volume 1 Year 457.36M
Range 3 Year
12.28 17.15
Volume 3 Year 1.71B
Range 10 Year
12.28 31.29
Volume 10 Year 3.56B

Highlights

Market Capitalization 43.69B (large)
Floating Shares 1.57B
Current Price 13.1
Price To Earnings 23.32
Price To Revenue 1.05
Price To Book 0
Earnings Per Share 0.59
Dividend Yield 4.22%
Dividend Per Share 0.58
Payout Ratio 48.61%

Performance

Latest +0.69%
1 Month -2.82%
3 Months -11.78%
6 Months +3.8%
1 Year -5.28%
3 Years -4.1%
5 Years -35.44%
10 Years -37.8%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.